Cantor Fitzgerald restated their neutral rating on shares of Universal Health Services (NYSE:UHS – Free Report) in a report released on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $219.00 target price on the health services provider’s stock. A number of other brokerages also recently commented on UHS. Robert W. Baird upped their target […]

Core Scientific (NASDAQ:CORZ – Get Free Report)‘s stock had its “overweight” rating reissued by Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $20.00 price target on the stock. Cantor Fitzgerald’s price target would suggest a potential upside of 64.07% from the stock’s current price. A number […]

Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They currently have a $116.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target points to a potential upside of 108.82% from the stock’s current price. Several other analysts […]

Cantor Fitzgerald reaffirmed their neutral rating on shares of Alphabet (NASDAQ:GOOGL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. Cantor Fitzgerald currently has a $190.00 price target on the information services provider’s stock. Other equities research analysts have also recently issued reports about the stock. Rosenblatt Securities reaffirmed […]

Perrigo (NYSE:PRGO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Canaccord Genuity Group in a note issued to investors on Monday, Benzinga reports. They currently have a $42.00 target price on the stock. Canaccord Genuity Group’s target price would suggest a potential upside of 64.93% from the company’s current price. […]

Zillow Group (NASDAQ:ZG – Get Free Report)‘s stock had its “neutral” rating reiterated by equities researchers at Cantor Fitzgerald in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $47.00 price target on the technology company’s stock. Cantor Fitzgerald’s target price suggests a potential downside of 25.05% from […]

Central Garden & Pet (NASDAQ:CENT – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Canaccord Genuity Group in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $48.00 price objective on the stock. Canaccord Genuity Group’s target price suggests a potential upside of […]